FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast cancer: Why it's difficult to treat and what new approaches are on the horizon

2.

Cancer during young adulthood carries long-term mental toll, study finds

3.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

4.

Study confirms link between breast density, higher breast cancer risk

5.

The discovery of drug combinations may increase the life expectancy of children with brain cancer.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot